Pages that link to "Q24630848"

The following pages link to Emerging drugs for uveitis (Q24630848):

Displaying 41 items.

• Role of dendritic cell subsets in immunity and their contribution to noninfectious uveitis (Q26852793) (← links)
• Medical management of uveitis - current trends (Q27003399) (← links)
• Turning Down the Thermostat: Modulating the Endocannabinoid System in Ocular Inflammation and Pain (Q28066928) (← links)
• Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis (Q28080084) (← links)
• Autoimmune uveitis: a retrospective analysis of 104 patients from a tertiary reference center. (Q33939523) (← links)
• Small heat shock protein αA-crystallin prevents photoreceptor degeneration in experimental autoimmune uveitis (Q34221494) (← links)
• A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis (Q34257553) (← links)
• Pharmacotherapy for uveitis: current management and emerging therapy (Q34274075) (← links)
• Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis (Q34530196) (← links)
• Systemic therapies for inflammatory eye disease: past, present and future (Q34687332) (← links)
• Diagnostic techniques for inflammatory eye disease: past, present and future: a review. (Q34910419) (← links)
• Inhibition of experimental auto-immune uveitis by the A3 adenosine receptor agonist CF101. (Q35197058) (← links)
• Increased CD1c+ mDC1 with mature phenotype regulated by TNFα-p38 MAPK in autoimmune ocular inflammatory disease (Q35572220) (← links)
• Efficacy of infliximab in refractory Behçet's disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients (Q35699360) (← links)
• Use of the Fluocinolone Acetonide Intravitreal Implant for the Treatment of Noninfectious Posterior Uveitis: 3-Year Results of a Randomized Clinical Trial in a Predominantly Asian Population (Q35752563) (← links)
• Understanding autoimmunity in the eye: from animal models to novel therapies (Q36069594) (← links)
• Two Genetic Variations in the IRF8 region are associated with Behçet's disease in Han Chinese (Q36501135) (← links)
• Effective Arrestin-Specific Immunotherapy of Experimental Autoimmune Uveitis with RTL: A Prospect for Treatment of Human Uveitis (Q37149410) (← links)
• A review and update on orphan drugs for the treatment of noninfectious uveitis (Q37632096) (← links)
• Anti-inflammatory effects of cannabinoid CB(2) receptor activation in endotoxin-induced uveitis. (Q37637761) (← links)
• Susceptibility genes and pharmacogenetics in ocular inflammatory disorders (Q38043013) (← links)
• Pharmacogenetics of drugs used in the treatment of ocular inflammatory diseases (Q38092131) (← links)
• Overview and recent developments in the medical management of paediatric uveitis (Q38119243) (← links)
• Pediatric uveitis: new and future treatments (Q38123032) (← links)
• Management of pediatric uveitis. (Q38225872) (← links)
• Autoimmune uveitis: clinical, pathogenetic, and therapeutic features. (Q38395263) (← links)
• Moving forward in uveitis therapy: preclinical to phase II clinical trial drug development (Q38660708) (← links)
• Principles of Ocular Pharmacology (Q38812551) (← links)
• Protective effects of the galectin-1 protein on in vivo and in vitro models of ocular inflammation. (Q38833613) (← links)
• Production and characterization of a CD25-specific scFv-Fc antibody secreted from Pichia pastoris (Q39224359) (← links)
• Pharmacologic Treatment of Noninfectious Uveitis. (Q40450258) (← links)
• Specific association of IL17A genetic variants with panuveitis. (Q41573022) (← links)
• Surveying uveitis specialists-a call for consensus (Q42074249) (← links)
• Augmenting Endogenous Levels of Retinal Annexin A1 Suppresses Uveitis in Mice (Q43270658) (← links)
• Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation. (Q47442388) (← links)
• Successful treatment of an overlapping choriocapillaritis between multifocal choroiditis and acute zonal occult outer retinopathy (AZOOR) with adalimumab (Humira™). (Q50478989) (← links)
• Dexamethasone intravitreal implant: an effective adjunctive treatment for recalcitrant noninfectious uveitis. (Q53793193) (← links)
• Tolerance Induction in Relation to the Eye (Q57816711) (← links)
• Improvement of neurological and ocular symptoms of Behçet's disease after the introduction of infliximab (Q88733373) (← links)
• Topical cyclosporine A therapy for dry eye syndrome (Q90093016) (← links)
• The effect of methotrexate and sulfasalazine on the course of HLA-B27-positive anterior uveitis: results from a retrospective cohort study (Q90704178) (← links)